| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 2, 2016New Sub-study at ACC.16 from the CoreValve U.S. High Risk Trial Shows Exceptional Valve Performance for the Self-Expanding Transcatheter Heart Valve at Two Years
DUBLIN and CHICAGO - April 2, 2016 - Medtronic plc (NYSE: MDT) today unveiled new clinical data on the self-expanding CoreValve® System from the High Risk Study of the CoreValve U.S. Pivotal...
-
Mar 31, 2016
DUBLIN - March 31, 2016 - Medtronic plc (the "Company") (NYSE: MDT) today announced the commencement of a cash tender offer (the "Tender Offer") by its wholly-owned subsidiaries, Medtronic, Inc....
-
Mar 29, 2016Medtronic Foundation Seeks Runners Benefitting from Medical Technology for 2016 "Global Heroes" TeamApplications now open: www.medtronic.com/globalheroes
DUBLIN - March 29, 2016 - Applications are now open for the 2016 Global Heroes running team. Every October since 2006, the Medtronic Foundation and Twin Cities In Motion have brought people from...
-
Mar 17, 2016
DUBLIN - March 17, 2016 - Medtronic plc (NYSE: MDT) will put forth a board proposal supporting the adoption of proxy access in its 2016 proxy statement. Proxy access would allow long-term...
-
Mar 4, 2016
DUBLIN - Mar 4, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced it will participate in the 36th Annual Cowen & Company Healthcare...
-
Mar 4, 2016
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Mar 1, 2016
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Feb 25, 2016- Fourth Quarter 2015 Revenue of $68.1 Million
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Feb 19, 2016
DUBLIN - February 19, 2016 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2016 fourth quarter cash dividend of $0.38 per ordinary share, representing a 25...
-
Feb 2, 2016HeartWare Presentation At The Leerink Partners 5th Annual Global Healthcare Conference To Be Webcast
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
